About Innopharma Group
Established in 2009 by a team of engineers and managers from some of Ireland's leading pharma companies, Innopharma Group are leaders in providing solutions for the high-tech future of manufacturing and industry 4.0.
Our Technology company design and develop pharma 4.0 data and technology solutions to help pharma development and manufacturing teams improve their processes and deliver better outcomes in drug manufacturing.
Our Services team provide skilled contractors to the pharma industry, particularly in the validation space.
Innopharma Technology: Smarter Drug Development
Innopharma Labs were one of only two Irish companies to receive funding from the EU's Horizon 2020 programme in 2018, and one of 65 EU based companies to receive funding in the latest round.
Horizon 2020 is the biggest ever EU Research and Innovation programme, with nearly €80 billion of funding available over 7 years (2014 to 2020). The fund was established to encourage breakthrough discoveries and world-firsts, taking great ideas from the lab to the market.
The European Commission received 1,644 proposals from a broad range of sectors, and a proposal and competitive pitch process was used to select the final 65. The funding allows companies with new innovations to take a product idea from initial lab based proof of concept and scale it for market launch through support for activities like demonstrations and testing, as well as through coaching and acceleration services.